info

product name:

Tenofovir Alafenamide Fumarate

cas No. :

1392275-56-7

MF :

2(C21H29N6O5P).C4H4O4

MW :

1069.02

Taian, China

9/F,E-commerce Industrial Park

+86 156 6659 0861

Mon to Fri 8am to 6 pm

sales@taiangreenindustry.com

Send us your inquiry anytime!

Detail

Quick Details

Synonyms:

GS 7340-03;

N-[(S)-[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-L-alanine 1-methylethyl ester (2E)-2-butenedioate (2:1)

Molecular structure:

Properties

Item

Specifications

Results

Appearance

White to off-white powder

White powder

Assay

≥99%

99.2%

Any single impurity

≤0.1%

0.02%

Moisture

≤1%

0.6%

Heavy metals

≤20ppm

12ppm

Conclusion

The results conforms with enterprise standards

 

Usage

Tenofovir alafenamide (TAF), a novel nucleotide reverse transcriptase inhibitor developed by Gilead, treats chronic hepatitis B virus infection and compensatory liver disease. Tenofovir alafluamine is an oral prodrug of tenofovir (TFV), a modified version of the marketed drug tenofovirdisoproxil fumarate (TDF), compared to TDF, TAF clinically The dosage is smaller, and it is easier to enter the cell to exert the effect, the antiviral effect is stronger, and the adverse reaction is reduced.

Packaging

25kg/drum

Storage

Store in a dry, well-ventilated place away from direct sunlight.

COA, TDS,